-
College Cork (UCC) is looking for two highly motivated Post-Doctoral Researchers. The researchers will be employed on a technology development project in which UCC collaborates with two companies, Danalto
-
on conducting a comprehensive Health Technology Assessment (HTA), synthesising evidence on clinical effectiveness and safety, pharmacoeconomic and cost-effectiveness outcomes, budget impact, organisational and
-
implementation of pharmacogenomics and multiomics in clinical practice. The role will focus on conducting a comprehensive Health Technology Assessment (HTA), synthesising evidence on clinical effectiveness and
-
technology development project in which UCC collaborates with two companies, Danalto and Qorvo. The UCC part of the project focuses on the development of agentic AI and digital twin concepts for Ultra-Wideband
-
21 Aug 2026 Job Information Organisation/Company University College Cork Department HR Research Research Field Engineering Researcher Profile Recognised Researcher (R2) Positions Postdoc Positions
-
14 Aug 2026 Job Information Organisation/Company University College Cork Department HR Research Research Field Engineering Researcher Profile Recognised Researcher (R2) Positions Postdoc Positions
-
to [email protected] For further information on the hiring unit, please see: https://www.ucc.ie/en/ore/ University College Cork is committed to being a fully inclusive global university which actively recruits
-
this competition following the conclusion of the process. Informal inquiries can be made in confidence to [email protected] For further information on the hiring unit, please see: https://www.ucc.ie/en/ore
-
, School of Computer Science & IT, Email: [email protected] For further information on NASC Research, visit https://www.ucc.ie/en/nascresearch/ University College Cork is committed to being a fully
-
candidate will be hosted at the Process and Chemical Engineering Department. For more details see https://www.ucc.ie/en/processeng/ Project Summary Antisense oligonucleotides (ASO) are novel alternative gene